FindTrial
Sign In

ASSESSMENT OF FUNCTION OF HEART DURING TREATMENT FOR ESOPHAGEAL CANCER

MONITORING CARDIAC FUNCTIONS DURING CONCURRENT CHEMORADIOTHERAPY IN OESOPHAGEAL CANCER: A MUGA SCAN AND ECHOCARDIOGRAPHY BASED EVALUATION

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2015/02/005502
Enrollment
15
Registered
2015-02-05
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- carcinoma esophagus

Interventions

None listed

Sponsors

PGIMER
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Surgically Inoperable upper/ middle/ lower thoracic oesophageal carcinoma 2. Histopathologically proven squamous cell / adenocarcinoma of esophagus 3. KPS >70

Exclusion criteria

Exclusion criteria: 1. Prior history of irradiation to the chest. 2. KPS 3. Prior history of cardiovascular disease that might interfere with the present study, like ischemic heart disease / rheumatic heart disease / cardiomyopathy etc. 4. Uncontrolled co-morbidities like diabetes and hypertension 5. Those not suitable for chemoradiation

Design outcomes

Primary

MeasureTime frame
1. To evaluate the acute changes in cardiac function during concurrent chemoradiation in patients of locally advanced esophageal cancer using MUGA scan and Echocardiography.Timepoint: 6 weeks—

Secondary

MeasureTime frame
To correlate the statistically significant changes in cardiac function, with the doses received by various cardiac regions Timepoint: 6 weeks—

Countries

India

Contacts

Public ContactDR RAVITEJA MIRIYALA

PGIMER, CHANDIGARH

drkapoor.r@gmail.com9872648344

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026